|
RGPD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.96139999997236E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.622300E-04 |
| Normal-vs-Stage2 |
2.436500E-02 |
| Normal-vs-Stage3 |
1.05510000003584E-06 |
| Normal-vs-Stage4 |
1.93509996915253E-09 |
| Stage1-vs-Stage2 |
8.051400E-01 |
| Stage1-vs-Stage3 |
8.943700E-02 |
| Stage1-vs-Stage4 |
1.403690E-03 |
| Stage2-vs-Stage3 |
2.202600E-01 |
| Stage2-vs-Stage4 |
4.069700E-02 |
| Stage3-vs-Stage4 |
1.985020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09549999996561E-06 |
| Normal-vs-AfricanAmerican |
1.61300000001141E-06 |
| Normal-vs-Asian |
3.520500E-02 |
| Caucasian-vs-AfricanAmerican |
2.023200E-01 |
| Caucasian-vs-Asian |
3.155700E-04 |
| AfricanAmerican-vs-Asian |
2.20159999999581E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.785400000065E-07 |
| Normal-vs-Female |
1.455240E-03 |
| Male-vs-Female |
6.462600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.016200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.997800E-04 |
| Normal-vs-Age(61-80Yrs) |
5.4708999996933E-07 |
| Normal-vs-Age(81-100Yrs) |
2.245800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.316190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.792600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.006200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.902300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.928000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.977200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.278000E-01 |
| Normal-vs-Grade 2 |
3.640900E-03 |
| Normal-vs-Grade 3 |
4.61799998241474E-09 |
| Normal-vs-Grade 4 |
4.39460023926586E-10 |
| Grade 1-vs-Grade 2 |
8.128600E-01 |
| Grade 1-vs-Grade 3 |
9.010000E-02 |
| Grade 1-vs-Grade 4 |
1.025680E-02 |
| Grade 2-vs-Grade 3 |
4.839600E-04 |
| Grade 2-vs-Grade 4 |
1.59504999999172E-05 |
| Grade 3-vs-Grade 4 |
9.968400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.309570E-02 |
| Normal-vs-ccB subtype |
1.67100000003639E-06 |
| ccA subtype-vs-ccB subtype |
6.141700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.06940000000633E-05 |
| Normal-vs-N1 |
1.789380E-04 |
| N0-vs-N1 |
3.734200E-02 |
|
|
